EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Upregulation of ABLIM1 Differentiates Intrahepatic Cholangiocarcinoma from Hepatocellular Carcinoma and Both Colorectal and Pancreatic Adenocarcinoma Liver Metastases

Tina Draškovič iD, Branislava Ranković iD, Nina Zidar iD, Nina Hauptman iD

Genes · 2024

DOI: 10.3390/genes15121545 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, 2024. Verfasst von Tina Draškovič und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pathology, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia. Hauptthemen laut MEDLINE: Liver Neoplasms, Cholangiocarcinoma, Carcinoma, Hepatocellular, Colorectal Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Slovenian Research and Innovation Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Altered gene expression in cancers holds great potential to improve the diagnostics and differentiation of primary and metastatic liver cancers. In this study, the expression of the protein-coding genes ring finger protein 135 (RNF135), ephrin-B2 (EFNB2), ring finger protein 125 (RNF125), homeobox-C 4 (HOXC4), actin-binding LIM protein 1 (ABLIM1) and oncostatin M receptor (OSMR) and the long non-coding RNAs (lncRNA) prospero homeobox 1 antisense RNA 1 (PROX1-AS1) and leukemia inhibitory factor receptor antisense RNA 1 (LIFR-AS1) was investigated in hepatocellular carcinoma, cholangiocarcinoma, colorectal liver metastases and pancreatic ductal adenocarcinoma liver metastases.

Methods

This study included 149 formalin-fixed, paraffin-embedded samples from 80 patients. After RNA isolation, quantification, reverse transcription and preamplification, real-time qPCR was performed. The gene expression between different groups was calculated relative to the expression of the reference genes using the ∆∆Cq method and statistically analyzed. The expression of the genes was additionally analyzed using the AmiCA and UCSC Xena platforms.

Results

In primary cancers, our results showed differential expression between primary tumors and healthy tissues for all the genes and lncRNA examined. Moreover, we found downregulation of RNF135 in hepatocellular carcinoma, downregulation of OSMR in colorectal liver metastases and upregulation of HOXC4 in cholangiocarcinoma compared to primary liver cancers and metastatic cancers. The major finding is the upregulation of ABLIM1 in cholangiocarcinoma compared to hepatocellular carcinoma, colorectal liver metastases, pancreatic ductal adenocarcinoma liver metastases and healthy liver tissue. We propose ABLIM1 as a potential biomarker that differentiates cholangiocarcinoma from other cancers and healthy liver tissue.

Conclusions

This study emphasizes the importance of understanding the differences in gene expression between healthy tissues and primary and metastatic cancers and highlights the potential use of altered gene expression as a diagnostic biomarker in these malignancies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsCholangiocarcinomaCarcinoma, HepatocellularColorectal NeoplasmsGene Expression Regulation, NeoplasticHumansMaleFemalePancreatic NeoplasmsUp-RegulationBiomarkers, TumorMiddle AgedBile Duct NeoplasmsLIM Domain ProteinsAgedRNA, Long NoncodingDiagnosis, DifferentialAdenocarcinomaAdult

Stichwörter der Autor:innen

ABLIM1cholangiocarcinomacolorectal carcinomacolorectal liver metastasesgene expressionhepatocellular carcinomalncRNAmRNApancreatic adenocarcinoma liver metastasespancreatic ductal adenocarcinoma

Substanzen

Biomarkers, TumorLIM Domain ProteinsRNA, Long Noncoding

Autor:innen und Institutionen

  • Institute of Pathology, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia.

ORCID-Profile: Tina Draškovič, Branislava Ranković, Nina Zidar, Nina Hauptman

Förderung

  • Slovenian Research and Innovation Agency

Zitieren

APA

Draškovič, T., Ranković, B., Zidar, N., & Hauptman, N. (2024). Upregulation of ABLIM1 Differentiates Intrahepatic Cholangiocarcinoma from Hepatocellular Carcinoma and Both Colorectal and Pancreatic Adenocarcinoma Liver Metastases. Genes. https://doi.org/10.3390/genes15121545

Vancouver

Draškovič T, Ranković B, Zidar N, Hauptman N. Upregulation of ABLIM1 Differentiates Intrahepatic Cholangiocarcinoma from Hepatocellular Carcinoma and Both Colorectal and Pancreatic Adenocarcinoma Liver Metastases. Genes. 2024. doi:10.3390/genes15121545

BibTeX
@article{Drakovi2024,
  author = {Draškovič, Tina and Ranković, Branislava and Zidar, Nina and Hauptman, Nina},
  title = {Upregulation of ABLIM1 Differentiates Intrahepatic Cholangiocarcinoma from Hepatocellular Carcinoma and Both Colorectal and Pancreatic Adenocarcinoma Liver Metastases},
  journal = {Genes},
  year = {2024},
  doi = {10.3390/genes15121545}
}
Kostenlos starten →